BCTX BriaCell Therapeutics Corp. Stock Quote

BCTX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	18.90%	Shs Outstand	14.33M	Perf Week	4.11%
Market Cap	112.65M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.01M	Perf Month	37.89%
Income	-	PEG	-	EPS next Q	-	Inst Own	33.63%	Short Float	4.89%	Perf Quarter	43.43%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.12	Perf Half Y	100.00%
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Target Price	-	Perf Year	25.73%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	2.81 - 9.00	Perf YTD	88.49%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-12.67%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	179.23%	ATR	0.60
Employees	-	Current Ratio	-	Sales Q/Q	-	Oper. Margin	-	RSI (14)	67.39	Volatility	8.30% 9.35%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.71	Prev Close	7.56
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	2.09M	Price	7.86
Recom	-	SMA20	18.12%	SMA50	35.51%	SMA200	71.18%	Volume	1,497,104	Change	3.97%

Sep-16-21 09:00AM	BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30 GlobeNewswire +5.44%
Sep-09-21 09:00AM	BriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed Warrants GlobeNewswire +5.46%
Sep-01-21 09:15AM	BriaCell Therapeutics Appoints Marc Lustig to its Board of Directors GlobeNewswire
Aug-23-21 08:00AM	BriaCell to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 GlobeNewswire
Aug-19-21 08:00AM	BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer GlobeNewswire -9.47%
Aug-16-21 08:30AM	Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 ACCESSWIRE -11.83%
Jul-14-21 07:22AM	BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment GlobeNewswire -9.57%
Jul-12-21 08:00AM	BriaCell to Present at Three Upcoming Investor Conferences GlobeNewswire
Jul-08-21 11:20AM	50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 ACCESSWIRE -8.46%
Jun-16-21 08:05AM	BriaCell Therapeutics Expands Breast Cancer Platform Technology into Prostate, Melanoma, and Lung Cancers GlobeNewswire +8.96%
Jun-10-21 08:05AM	BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises GlobeNewswire
Jun-09-21 08:05AM	BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET GlobeNewswire +13.40%
Jun-07-21 07:50PM	BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement GlobeNewswire +8.16%
Jun-03-21 10:31AM	IIROC Trading Resumption - BCT CNW Group
09:41AM	BriaCell Therapeutics Corp. Announces US$27.2 Million Private Placement GlobeNewswire
08:38AM	IIROC Trading Halt - BCT CNW Group
Jun-02-21 07:12AM	BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of Eye-Bulging Tumor GlobeNewswire +94.34%
May-19-21 05:15PM	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting GlobeNewswire
May-11-21 06:30AM	BriaCell to Participate at Upcoming Conferences and Appoints Senior R&D Director GlobeNewswire
Apr-25-21 05:18AM	Insider Buying: The BriaCell Therapeutics Corp. (CVE:BCT) CEO, President & Director Just Bought 124% More Shares Simply Wall St.
Apr-21-21 08:00AM	BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com GlobeNewswire
Apr-15-21 06:00PM	BriaCell Announces Investor and Media Outreach Programs GlobeNewswire
Apr-12-21 01:45PM	BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million GlobeNewswire -24.76%
06:30AM	BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021 GlobeNewswire
Mar-30-21 06:30AM	BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021 GlobeNewswire
Feb-26-21 02:24PM	BriaCell Announces Closing of US$25 Million Public Offering GlobeNewswire -8.11%

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience